VRTX Earnings

Quarterly EPS
$3.55
Q4 2024
$2.52
Q1 2025
$4.02
Q2 2025
$4.24
Q3 2025
$4.70
Q4 2025
$4.06
Q1 2026
$4.34
Q2 2026
$2.58
Q3 2026
Latest Revenue3.4B
Latest Net Income653.6M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026$2.583.4B653.6M+11.8%-39.2%
Q2 2026$4.343.3B1.1B+12.5%+8.0%
Q1 2026$4.063.0B1.0B+7.8%+61.1%
Q4 2025$4.703.2B1.2B+9.5%+32.4%
Q3 2025$4.243.1B1.1B+11.0%+4.7%
Q2 2025$4.023.0B1.0B+12.1%+128.9%
Q1 2025$2.522.8B646.3M+3.0%-40.8%
Q4 2024$3.552.9B913.0M+15.7%-5.6%
Q3 2024$4.052.8B1.0B——
Q2 2024-$13.922.6B-3593600000——
Q1 2024$4.262.7B1.1B——
Q4 2023$3.762.5B968.8M——
Vertex Pharmaceuticals (VRTX) — Earnings